205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.47%
Revenue growth 1.25-1.5x INTC's 5.25%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
13.31%
Gross profit growth similar to INTC's 12.64%. Walter Schloss would assume both firms track common industry trends.
37.52%
EBIT growth 1.25-1.5x INTC's 28.87%. Bruce Berkowitz would verify if strategic initiatives are driving this edge.
-6.84%
Negative operating income growth while INTC is at 28.87%. Joel Greenblatt would press for urgent turnaround measures.
-4.70%
Negative net income growth while INTC stands at 47.50%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-5.08%
Negative EPS growth while INTC is at 47.50%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-3.45%
Negative diluted EPS growth while INTC is at 48.72%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.63%
Share reduction while INTC is at 0.06%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.54%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
0.31%
Maintaining or increasing dividends while INTC cut them. John Neff might see a strong edge in shareholder returns.
70.77%
OCF growth above 1.5x INTC's 21.37%. David Dodd would confirm a clear edge in underlying cash generation.
77.99%
FCF growth above 1.5x INTC's 43.29%. David Dodd would verify if the firm’s strategic investments yield superior returns.
100.90%
10Y revenue/share CAGR at 75-90% of INTC's 125.21%. Bill Ackman would press for new markets or product lines to narrow the gap.
13.95%
5Y revenue/share CAGR under 50% of INTC's 48.45%. Michael Burry would suspect a significant competitive gap or product weakness.
-6.30%
Negative 3Y CAGR while INTC stands at 35.93%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
254.02%
10Y OCF/share CAGR above 1.5x INTC's 135.20%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
30.17%
Below 50% of INTC's 96.13%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-5.66%
Negative 3Y OCF/share CAGR while INTC stands at 79.32%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
120.73%
Similar net income/share CAGR to INTC's 132.93%. Walter Schloss would see parallel tailwinds or expansions for both firms.
32.93%
5Y net income/share CAGR at 50-75% of INTC's 64.77%. Martin Whitman might see a shortfall in operational efficiency or brand power.
-20.90%
Negative 3Y CAGR while INTC is 11.74%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
51.69%
10Y equity/share CAGR at 50-75% of INTC's 94.19%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
30.26%
5Y equity/share CAGR at 50-75% of INTC's 60.31%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
19.84%
3Y equity/share CAGR at 50-75% of INTC's 30.13%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
1205.79%
10Y dividend/share CAGR 1.25-1.5x INTC's 1019.61%. Bruce Berkowitz confirms if a higher payout growth rate remains sustainable long term.
179.73%
5Y dividend/share CAGR above 1.5x INTC's 61.05%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
132.68%
3Y dividend/share CAGR above 1.5x INTC's 43.07%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
2.21%
AR growth is negative/stable vs. INTC's 7.05%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
0.35%
We show growth while INTC is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-0.79%
Negative asset growth while INTC invests at 5.71%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
0.48%
Under 50% of INTC's 2.93%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-0.08%
We’re deleveraging while INTC stands at 0.70%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-5.40%
Our R&D shrinks while INTC invests at 8.98%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-1.27%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.